A randomized controlled clinical trial to evaluate the clinical efficacy of indigenously designed and produced titanium dental implant
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2022/06/043437
- Lead Sponsor
- Datta Meghe Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Absence of one/two tooth bilaterally in maxilla
or mandible
2. Periodontal Healthy Adults above 18 years of
age
3. Good general health of the individuals whose
ASA score is 1-2
4. Absence of systemic diseases.
5. Sufficient bone volume with 4 months post-
extraction healing time
6.Patient giving his/her informed consent and
willing to participate in the study.
1. Immunocompromised patients
2. Poor oral hygiene
3. Adults with parafunctional habits like bruxism
etc.
4. Adults with allergy to titanium or titanium
alloys.
5. Pregnant woman or breastfeeding.
6. Heavy smoker; more than 10 cigarettes in a
day.
7. Patients on systemic corticosteroids for
long term
8. Patients with history of radiation therapy
in the head and neck region.
9. Refusal of patient to participate in the
study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Implant Survival <br/ ><br>2. Implant Success <br/ ><br>3. Mean Bone level as evaluated using radiographTimepoint: At 6 and 12 months from baseline
- Secondary Outcome Measures
Name Time Method 1. Mean osseointegration period <br/ ><br>2. Dental Plaque Assessment <br/ ><br>3. Papillary Bleeding Index <br/ ><br>4. Periodontal Pocket DepthTimepoint: At 3, 6 and 12 months from baseline